In 2021, Germany has announced its plan to legalize cannabis for recreational purposes. The legalization process is currently ongoing and, if implemented, could have a profound impact on the nation’s emerging cannabis industry, including the medical cannabis sector. The launch of the world’s largest regulated national adult-use cannabis industry in Germany would usher in a new era for the international cannabis space, and related innovations would drive the global industry forward. Attorney Peter Homberg, partner at leading business law firm Dentons, will provide an update on current developments in the legalization process in Germany. Homberg will also discuss developments in the medical cannabis sector, and inter alia address the implications of the proposals to amend the Medicinal Products Guideline (Arzneimittel-Richtlinie) by the Federal Joint Committee (Gemeinsamer Bundesausschuss – G-BA).
Various countries are working toward adult-use cannabis legalization to some degree, although none of them are as close as Germany to joining the small group of legalized nations. Germany is aiming to become the first nation in Europe to launch a regulated, for-profit adult-use industry at the national level. Legalization in Germany will usher in a new era of global reform efforts. How likely is it that cannabis storefronts come to Germany in the near future? Will Germany be able to solve the issues regarding EU law and other major problems? And if so, what will legalization in Germany look like? Georg will provide a brief overview and the latest developments.
Germany is the most exciting country on earth right now when it comes to cannabis policy and industry, with German lawmakers currently pursuing the largest adult-use cannabis legalization and regulatory effort in human history. The German Cannabis Business Association (BvCW e.V.) is once again hosting the political discussion panel at ICBC Berlin and has invited members of the German Bundestag from all relevant parties. Panelists will discuss a variety of cannabis political issues, including the development of stimulant regulation, adult-use legalization, medical cannabis policy, commercial hemp, and CBD.
Germany has emerged as a key player in the global medical cannabis market, with a robust regulatory framework and a growing number of patients accessing cannabis for therapeutic use. But Germany is not alone in its pursuit of medical cannabis. Around the world, countries are exploring the potential of cannabis to treat a range of conditions, from chronic pain to epilepsy to cancer. In this panel, experts from Germany and beyond take a closer look at the role of Germany in the medical cannabis industry and to explore the emerging markets and pilot programs around the world. The panel also discusses the critical importance of education for healthcare professionals, patients, and policymakers to ensure the safe and effective use of medical cannabis.
The emerging international cannabis industry is currently governed by a complex web of laws, rules, and regulations that are constantly shifting and evolving. With more countries reforming their cannabis policies and regulations, the regulatory layers will continue to increase in volume for the foreseeable future. Yoram Eshel, CEO of Cannabilog, will present tips and insight regarding how to navigate the ‘regulatory maze’ in an effective way. Eshel will analyze current international supply chain trends, provide an update on regulatory requirements in various markets, and discuss what to anticipate soon. He will also discuss the ‘do’s and don’ts’ when shipping cannabis products worldwide.
For the future of the German cannabis industry, spring 2023 will prove to be a decisive time in history. The draft law from the Ministry of Health, several expert opinions and counter-opinions, as well as a decision by the Federal Constitutional Court on the legality of cannabis prohibition are all expected to occur. What do German and international companies think about these developments? And what are the next steps for them? We will discuss these political questions and their very practical consequences in this panel featuring major players from the emerging cannabis industry.
The cannabis industry is one of the most heavily regulated industries in the world, with a complex and ever-changing landscape of laws and regulations at the federal, state, and local levels. In this panel, our experts explore the key regulatory and compliance issues facing cannabis businesses today, and discuss best practices for staying on the right side of the law. From licensing and permitting to tax compliance and product safety, they cover the most pressing issues facing the industry and offer insights into how businesses can navigate these challenges.
As the cannabis industry moves into a new era of scientific exploration, the potential for breakthroughs in biotech and medical research is vast. From unlocking the secrets of the plant’s medicinal properties to developing new cannabis-based therapies, the future of cannabis research is full of promise. In this panel, the panelists explore the latest innovations in cannabis biotech and discuss the opportunities and challenges of conducting research in this exciting and rapidly evolving field.
Cannabis breeding is an essential part of the industry, as it allows for the development of new strains and products that can be tailored to meet the needs of different consumers. As the cannabis market continues to grow and evolve, so does the potential for genetics to play an even greater role in the industry. In this panel, the experts discuss the latest trends in cannabis genetics and explore the future of breeding, from identifying new traits to using CRISPR technology. This panel also delves into the question of how human DNA and cannabis DNA might be connected, and what implications this could have for the future of the industry.
As medical cannabis programs continue to expand around the world, it’s important to examine how these programs are actually working for patients. Are they providing safe, effective access to medicine? What challenges do patients face in navigating the complex regulatory landscape? And what can be done to improve patient outcomes and ensure that medical cannabis programs live up to their promise? In this panel, the audience hears from patients, industry and medical professionals about their experiences with medical cannabis programs, and will explore the key issues facing patients today.
Similar to the 1830s when Germany and the Czech Republic collaborated on the standardization of Pilsner beer, the two countries are now collaborating on cannabis reform. This presentation will provide an update on the adult-use legalization efforts in the EU, provide a total-market EU forecast, and demonstrate with data how Germany and the Czech Republic will have a major influence on the legal EU cannabis market going forward.
The cannabis industry is rapidly expanding worldwide, with new markets and production countries emerging at an unprecedented rate. As more and more countries legalize medical and/or recreational cannabis, the opportunities for businesses to tap into these new markets are growing, but so are the challenges. This panel will explore the emerging cannabis sales markets and production countries, the potential for growth and investment, and the unique regulatory and legal considerations that businesses must navigate.
The industrial hemp industry has grown exponentially in recent years, but navigating the regulations surrounding THC content and product standards can be a challenge. From varying THC limits to different regulations for different finished products, the legal landscape for industrial hemp is complex. Different countries have set varying limits on the amount of THC that industrial hemp can contain, ranging from 0.2% to 1%, which can affect the cultivation, processing, and sale of different hemp products. In this panel, experts will explore the patchwork of regulations that apply to industrial hemp, including the different THC limits and product standards, The experts will explore the challenges and opportunities of navigating this regulatory maze and discuss the latest developments in the industry from a regulatory perspective.
When it comes to cannabis, packaging is not just about compliance, it’s about style. From pre-rolls to edibles and everything in between, the right packaging can make all the difference in capturing the attention of your target audience. But with so many options on the market, how do you know which packaging solution is right for you? In this panel, our professionals will explore the latest trends and innovations in cannabis packaging and discuss the relevance of different solutions for the various segments of the industry.
Terpenes are a class of organic compounds found in many plants, including cannabis, that are responsible for the distinctive aroma and flavor of different strains. But terpenes are also believed to play a role in the effects of cannabis, with different combinations of terpenes thought to produce different physical and psychological effects. In this panel, our experts will explore the latest research on terpenes and the potential for matching cannabis strains with their effects. The panel also discusses the risks and opportunities of using terpenes to guide strain selection, as well as the challenges of ensuring consistent and reliable experiences for consumers.
As the cannabis industry continues to grow and evolve, digital technology is poised to play an increasingly important role. From seed-to-sale tracking to customer relationship management, cannabis businesses are turning to software-as-a-service (SaaS) solutions, mobile apps, web 2.0 and big data analytics to improve efficiency, compliance, and customer experience. In this panel, tech specialists will explore the latest trends and opportunities in cannabis technology, and discuss how digital tools can help businesses stay ahead in a rapidly changing industry.
Track and trace systems have become increasingly critical in many industries, including cannabis, where compliance requirements are high and product safety is paramount. These systems can help to prevent counterfeiting, control product dispersion, and improve supply chain transparency. In this panel, experienced professionals explore how track and trace systems are being implemented in the cannabis industry and discuss the lessons that can be applied to other industries facing similar challenges.
The global drug control policy landscape is shifting rapidly, with many countries and international organizations re-evaluating their approach to cannabis and other drugs. But despite growing support for reform, significant challenges remain, including powerful opposition from entrenched interests and a lack of political will in some areas. In this panel, experienced thought-leaders explore the latest developments in global drug control policy and their implications for the cannabis industry. The panelists discuss the role of lobbying and advocacy in shaping policy reform, and how the cannabis industry can work with policymakers to advance a more rational and humane approach to drug policy.
© 2014- International Conferences Group | All rights reserved | Site developed and hosted by Rogue Web Works.
Please wait while you are redirected to the right page...
Please share your location to continue.
Check our help guide for more info.